期刊文献+

基于心脑血管疾病风险评估问卷的心脑血管疾病风险评估初探 被引量:4

Preliminary exploration of cardiovascular and cerebrovascular disease risk assessment based on"Cardiovascular Disease Risk Assessment Questionnaire"
下载PDF
导出
摘要 目的基于心脑血管疾病风险评估问卷评估心脑血管疾病风险。方法对2018年1月至2020年6月期间以中国人民解放军总医院、山东省高密地区、河南省新密地区、贵州省锦屏地区多中心纳入的患者及家属进行“8+2问卷”调查,评估其心脑血管疾病相关风险。结果对总计78651名纳入者进行调查分析,其中本研究队列中,心脑血管疾病低危人群52236人(66.4%)、中危人群15385人(19.6%)、高危人群11029人(14.0%);男女性别间心脑血管疾病风险分级差异有统计学意义(P<0.001);各年龄组心脑血管疾病风险不同级别人数由低危至高危逐渐减少;对中年组(45~59岁)、中老年组(60~74岁)、老年组(75~89岁)共计76022名纳入者进行分析,不同年龄组的心脑血管疾病风险分级间两两相互比较,P值均<0.001。结论随着心脑血管疾病风险分级增高,人数相对减少,心脑血管疾病风险与性别有关,年龄越大患心脑血管疾病的风险更高。 Objective To analysis the cardiovascular and cerebrovascular diseases by"Cardiovascular Disease Risk Assessment Questionnaire".Methods The"Cardiovascular Disease Risk Assessment Questionnaire"survey was conducted among outpatients and inpatients enrolled in the multi-center of Gaomi region of Shandong Province,Xinmi region of Henan Province,and Haidian district of Beijing Province from January 2018 to June 2020 to assess their cardiovascular and cerebrovascular diseases risks.Results A total of 78651 enrollees were analyzed.In this study cohort,52236 participants(66.4%)were in the low-risk group of cardiovascular and cerebrovascular diseases,15385 participants(19.6%)were in the intermediate-risk group,and 11029 participants(14.0%)were in the high-risk group.The risk classification of cardiovascular and cerebrovascular diseases between male and female groups was compared,P<0.001 between two groups,and the results showed statistical differences.A total of 76022 participants between 45-89 years old were analyzed.They were divided into three groups:the middle-aged group(45-59 years old),middle-aged group(60-74 years old),and elderly group(75-89 years old).The number of people with different risk grades of cardiovascular and cerebrovascular diseases in each age group gradually decreased from low-risk to high-risk.Comparing the three groups in pairs,the P values are all<0.001.Conclusions As the risk of cardiovascular and cerebrovascular diseases increases,and the number of items is relatively reduced;risk of cardiovascular and cerebrovascular diseases is different between man and women;the risk of cardiovascular and cerebrovascular diseases increases with age.
作者 王海鑫 胡山 张燕 刘改芬 王曙霞 张润华 何荆贵 Wang Haixin;Hu Shan;Zhang Yan;Liu Gaifen;Wang Shuxia;Zhang Runhua;He Jinggui(Cadre Medical Department,the 1 st Clinical Center,Chinese PLA General Hospital,Beijing 100853,China;不详)
出处 《中国临床保健杂志》 CAS 2022年第3期345-348,共4页 Chinese Journal of Clinical Healthcare
基金 “十三五”国家重点研发计划项目(2017YFC1307700)。
关键词 心血管疾病 风险评估与减低 调查和问卷 Cardiovascular diseases Risk evaluation and mitigation Surveys and questionnaires
  • 相关文献

参考文献11

二级参考文献62

  • 1翟铁民,张毓辉,万泉,柴培培,郭锋,王从从,王秀峰.基于“卫生费用核算体系2011”的中国卫生费用核算方法学研究[J].中国卫生经济,2015,34(3):9-11. 被引量:90
  • 2王薇,赵冬,刘静,曾哲淳,孙佳艺,刘军,秦兰萍,吴兆苏.中国35~64岁人群胆固醇水平与10年心血管病发病危险的前瞻性研究[J].中华心血管病杂志,2006,34(2):169-173. 被引量:133
  • 3赵连成,周北凡,李莹,张红叶,武阳丰.人群血清胆固醇水平与膳食营养的关系[J].中国慢性病预防与控制,1996,4(5):195-199. 被引量:34
  • 4国家心血管病中心.中国心血管病报告2014[M].北京:中国大百科全书出版社,2015年1月,ISBN 978-7-5000-9510-1.
  • 5中华人民共和国卫生部.中国卫生和计划生育统计年鉴2014[M].北京:中国协和医科大学出版社,2015.
  • 6Li GW,Zhang P, Wang P,et al. Cardiovascular mortality, all - cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study. A 23 - year follow - up study[ J]. Lancet Diabetes Endocrinol, 2014,2(6) :474 -480.
  • 7Zhang Y, Zhang X, Liu L,et al. Is a systolic blood pressure target < 140mmHg indicated in all hypertensives? Subgroup analyses of find- ings from the randomized FEVER trial[J]. Ear Heart J,2011,32: 1500 ~ 1508.
  • 8Ma L, Wang W, Zhao Y,et al. Combination of amlodipine plus an- giotensin receptor blocker or diuretics in high - risk hypertensive pa- tients: a 96 - week efficacy and safety study [ J ]. Am J Cardiovase Drugs,2012 ,12(2) :137 - 142.
  • 9Huo Y, Li JP, Qin NH ,et al. Efficacy of folie acid therapy im prima- ry prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial[J]. JAMA,2015:2274.
  • 10叶林书,刘永东.美国CER和GWTG研究择撷与教益[J].中国医药导报,2009,6(34):120-124. 被引量:4

共引文献700

同被引文献38

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部